首页 > 最新文献

Open Medicinal Chemistry Journal最新文献

英文 中文
Amine Containing Analogs of Sulindac for Cancer Prevention. 含胺的舒林酸类似物预防癌症。
Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2018-01-31 eCollection Date: 2018-01-01 DOI: 10.2174/1874104501812010001
Bini Mathew, Judith V Hobrath, Michele C Connelly, R Kiplin Guy, Robert C Reynolds

Background: Sulindac belongs to the chemically diverse family of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) that effectively prevent adenomatous colorectal polyps and colon cancer, especially in patients with familial adenomatous polyposis. Sulindac sulfide amide (SSA), an amide analog of sulindac sulfide, shows insignificant COX-related activity and toxicity while enhancing anticancer activity in vitro and demonstrating in vivo xenograft activity.

Objective: Develop structure-activity relationships in the sulindac amine series and identify analogs with promising anticancer activities.

Method: A series of sulindac amine analogs were designed and synthesized and then further modified in a "libraries from libraries" approach to produce amide, sulfonamide and N,N-disubstituted sulindac amine sub-libraries. All analogs were screened against three cancer cell lines (prostate, colon and breast).

Results: Several active compounds were identified viain vitro cancer cell line screening with the most potent compound (26) in the nanomolar range.

Conclusion: Compound 26 and analogs showing the most potent inhibitory activity may be considered for further design and optimization efforts as anticancer hit scaffolds.

背景:舒林达克属于化学成分多样的非甾体抗炎药(NSAIDs)家族,可有效预防腺瘤性结直肠息肉和结肠癌,特别是对家族性腺瘤性息肉病患者。Sulindac sulfide amide (SSA)是Sulindac sulfide的酰胺类似物,在体外增强抗癌活性并在体内表现出异种移植物活性的同时,显示出不明显的cox相关活性和毒性。目的:建立舒林达胺系列化合物的构效关系,并鉴定具有抗癌活性的类似物。方法:设计合成一系列磺林达克胺类似物,采用“从库到库”的方法进行修饰,得到酰胺类、磺胺类和N,N-二取代的磺林达克胺亚库。所有类似物都对三种癌细胞系(前列腺癌、结肠癌和乳腺癌)进行了筛选。结果:在体外癌细胞筛选中发现了几种有效化合物,其中最有效的化合物(26)在纳摩尔范围内。结论:化合物26及其类似物具有较强的抑制活性,可作为抗肿瘤靶向支架进行进一步的设计和优化。
{"title":"Amine Containing Analogs of Sulindac for Cancer Prevention.","authors":"Bini Mathew,&nbsp;Judith V Hobrath,&nbsp;Michele C Connelly,&nbsp;R Kiplin Guy,&nbsp;Robert C Reynolds","doi":"10.2174/1874104501812010001","DOIUrl":"https://doi.org/10.2174/1874104501812010001","url":null,"abstract":"<p><strong>Background: </strong>Sulindac belongs to the chemically diverse family of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) that effectively prevent adenomatous colorectal polyps and colon cancer, especially in patients with familial adenomatous polyposis. Sulindac sulfide amide (SSA), an amide analog of sulindac sulfide, shows insignificant COX-related activity and toxicity while enhancing anticancer activity <i>in vitro</i> and demonstrating <i>in vivo</i> xenograft activity.</p><p><strong>Objective: </strong>Develop structure-activity relationships in the sulindac amine series and identify analogs with promising anticancer activities.</p><p><strong>Method: </strong>A series of sulindac amine analogs were designed and synthesized and then further modified in a \"libraries from libraries\" approach to produce amide, sulfonamide and N,N-disubstituted sulindac amine sub-libraries. All analogs were screened against three cancer cell lines (prostate, colon and breast).</p><p><strong>Results: </strong>Several active compounds were identified <i>via</i><i>in vitro</i> cancer cell line screening with the most potent compound (<b>26</b>) in the nanomolar range.</p><p><strong>Conclusion: </strong>Compound <b>26</b> and analogs showing the most potent inhibitory activity may be considered for further design and optimization efforts as anticancer hit scaffolds.</p>","PeriodicalId":39133,"journal":{"name":"Open Medicinal Chemistry Journal","volume":"12 ","pages":"1-12"},"PeriodicalIF":0.0,"publicationDate":"2018-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817852/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35872443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Intra Nasal In situ Gelling System of Lamotrigine Using Ion Activated Mucoadhesive Polymer. 使用离子活化粘液黏附聚合物的拉莫三嗪鼻内原位胶凝系统
Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2017-12-29 eCollection Date: 2017-01-01 DOI: 10.2174/1874104501711010222
Asha Paul, K M Fathima, Sreeja C Nair

Background: A novel drug delivery system for treating acute epileptic condition.

Objective: To develop an intranasal mucoadhesive formulation of Lamotrigine (LTG) loaded insitu gel, for the treatment of epilepsy to avoid possible side effects and first pass metabolism associated with conventional treatment.

Methods: Lamotrigine was loaded into different polymeric solutions of gellan and xanthan gum.

Results: All formulations subjected to various evaluation studies were within their acceptable limits. The pH of formulation ranges between 5.8 ±.001 to 6.8 ±.005 indicating that no mucosal irritation is expected as pH was in acceptable range. Invitro drug release from the mucoadhesive insitu gel formulations showed immediate drug release pattern with a maximum drug release of 97.02 ±0.54% for optimized G5 formulation within 20min. Exvivo permeation studies of optimized formulation G5 and control formulation was estimated. Exvivo permeation studies of G5 insitu formulation done for a period of 12 h resulted in slow, sustained release and greater permeability significance(P <0.05) through nasal mucosa when compared to control. Histopathological studies showed that G5 formulation was safer for nasal administration without any irritation. The stability studies indicated that gels were stable over 45 days in refrigerated condition (4±2ºC).

Conclusion: The intranasal insitu gelling system is a promising novel drug delivery system for an antiepileptic drug lamotrigine which could enhance nasal residence time with increased viscosity and mucoadhesive character and provided better release profile of drug for treating acute epileptic conditions.

背景:一种治疗急性癫痫的新型给药系统一种治疗急性癫痫的新型给药系统:目的:开发一种载入拉莫三嗪(LTG)的原位凝胶鼻内粘附制剂,用于治疗癫痫,以避免传统治疗可能产生的副作用和首过代谢:方法:将拉莫三嗪添加到不同的结冷胶和黄原胶聚合物溶液中:结果:所有经过各种评估研究的配方都在可接受的范围内。制剂的 pH 值在 5.8 ±.001 到 6.8 ±.005 之间,表明由于 pH 值在可接受范围内,因此不会对粘膜产生刺激。粘液粘附性原位凝胶制剂的体外药物释放显示出即时药物释放模式,优化的 G5 制剂在 20 分钟内的最大药物释放量为 97.02 ±0.54%。对优化配方 G5 和对照配方的体内渗透研究进行了估计。对 G5 原位制剂进行了长达 12 小时的体内渗透研究,结果表明该制剂具有缓慢、持续释放和更大的渗透性(P 结论):鼻腔内原位胶凝系统是一种很有前景的新型给药系统,可用于抗癫痫药物拉莫三嗪,它能通过增加粘度和黏附性来延长药物在鼻腔内的停留时间,并为治疗急性癫痫病提供更好的药物释放曲线。
{"title":"Intra Nasal <i>In situ</i> Gelling System of Lamotrigine Using Ion Activated Mucoadhesive Polymer.","authors":"Asha Paul, K M Fathima, Sreeja C Nair","doi":"10.2174/1874104501711010222","DOIUrl":"10.2174/1874104501711010222","url":null,"abstract":"<p><strong>Background: </strong>A novel drug delivery system for treating acute epileptic condition.</p><p><strong>Objective: </strong>To develop an intranasal mucoadhesive formulation of Lamotrigine (LTG) loaded <i>insitu</i> gel, for the treatment of epilepsy to avoid possible side effects and first pass metabolism associated with conventional treatment.</p><p><strong>Methods: </strong>Lamotrigine was loaded into different polymeric solutions of gellan and xanthan gum.</p><p><strong>Results: </strong>All formulations subjected to various evaluation studies were within their acceptable limits. The pH of formulation ranges between 5.8 ±.001 to 6.8 ±.005 indicating that no mucosal irritation is expected as pH was in acceptable range. <i>Invitro</i> drug release from the mucoadhesive <i>insitu</i> gel formulations showed immediate drug release pattern with a maximum drug release of 97.02 ±0.54% for optimized G5 formulation within 20min. <i>Exvivo</i> permeation studies of optimized formulation G5 and control formulation was estimated. <i>Exvivo</i> permeation studies of G5 <i>insitu</i> formulation done for a period of 12 h resulted in slow, sustained release and greater permeability significance(P <0.05) through nasal mucosa when compared to control. Histopathological studies showed that G5 formulation was safer for nasal administration without any irritation. The stability studies indicated that gels were stable over 45 days in refrigerated condition (4±2ºC).</p><p><strong>Conclusion: </strong>The intranasal <i>insitu</i> gelling system is a promising novel drug delivery system for an antiepileptic drug lamotrigine which could enhance nasal residence time with increased viscosity and mucoadhesive character and provided better release profile of drug for treating acute epileptic conditions.</p>","PeriodicalId":39133,"journal":{"name":"Open Medicinal Chemistry Journal","volume":"11 ","pages":"222-244"},"PeriodicalIF":0.0,"publicationDate":"2017-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769127/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35791963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ezqsar: An R Package for Developing QSAR Models Directly From Structures. Ezqsar:一个直接从结构中开发QSAR模型的R包。
Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2017-11-30 eCollection Date: 2017-01-01 DOI: 10.2174/1874104501711010212
Jamal Shamsara

Background: Quantitative Structure Activity Relationship (QSAR) is a difficult computational chemistry approach for beginner scientists and a time consuming one for even more experienced researchers.

Method and materials: Ezqsar which is introduced here addresses both the issues. It considers important steps to have a reliable QSAR model. Besides calculation of descriptors using CDK library, highly correlated descriptors are removed, a provided data set is divided to train and test sets, descriptors are selected by a statistical method, statistical parameter for the model are presented and applicability domain is investigated.

Results: Finally, the model can be applied to predict the activities for an extra set of molecules for a purpose of either lead optimization or virtual screening. The performance is demonstrated by an example.

Conclusion: The R package, ezqsar, is freely available via https://github.com/shamsaraj/ezqsar, and it runs on Linux and MS-Windows.

背景:定量结构活性关系(Quantitative Structure - Activity Relationship, QSAR)是一种对初学者来说比较困难的计算化学方法,对于经验丰富的研究人员来说更是费时费力。方法和材料:这里介绍的Ezqsar解决了这两个问题。它考虑了建立可靠的QSAR模型的重要步骤。在利用CDK库计算描述符的基础上,去除高度相关的描述符,将给定的数据集划分为训练集和测试集,采用统计方法选择描述符,给出模型的统计参数,研究模型的适用范围。结果:最后,该模型可用于预测一组额外分子的活性,用于先导优化或虚拟筛选。通过实例验证了该方法的性能。结论:R包ezqsar可以通过https://github.com/shamsaraj/ezqsar免费获得,它运行在Linux和MS-Windows上。
{"title":"Ezqsar: An R Package for Developing QSAR Models Directly From Structures.","authors":"Jamal Shamsara","doi":"10.2174/1874104501711010212","DOIUrl":"https://doi.org/10.2174/1874104501711010212","url":null,"abstract":"<p><strong>Background: </strong>Quantitative Structure Activity Relationship (QSAR) is a difficult computational chemistry approach for beginner scientists and a time consuming one for even more experienced researchers.</p><p><strong>Method and materials: </strong>Ezqsar which is introduced here addresses both the issues. It considers important steps to have a reliable QSAR model. Besides calculation of descriptors using CDK library, highly correlated descriptors are removed, a provided data set is divided to train and test sets, descriptors are selected by a statistical method, statistical parameter for the model are presented and applicability domain is investigated.</p><p><strong>Results: </strong>Finally, the model can be applied to predict the activities for an extra set of molecules for a purpose of either lead optimization or virtual screening. The performance is demonstrated by an example.</p><p><strong>Conclusion: </strong>The R package, ezqsar, is freely available <i>via</i> https://github.com/shamsaraj/ezqsar, and it runs on Linux and MS-Windows.</p>","PeriodicalId":39133,"journal":{"name":"Open Medicinal Chemistry Journal","volume":"11 ","pages":"212-221"},"PeriodicalIF":0.0,"publicationDate":"2017-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/1874104501711010212","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35781837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
Effects on Sperms' Quality of Selegiline in Aged Rats. 斯来吉兰对老龄大鼠精子质量的影响。
Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2017-11-30 eCollection Date: 2017-01-01 DOI: 10.2174/1874104501711010138
Huba Kalász, Julianna Thuróczy, Gellért Karvaly, Lajos Balogh, István Gyertyán, Edit Tóth-Molnár, Ernest Adeghate, Kornélia Tekes

Background: Selegiline is used to treat Parkinsonian patients. Other indications of its use have recently been discovered.

Objective: Scouting special and beneficial side effects of selegiline treatment.

Method: Two-year old male Wistar rats were daily treated with 0.25 mg/kg of selegiline s.c. (subcutaneous injection). The rats were sacrificed following a four-weeks' treatment.

Results: Mass of testes, number of sperms, progressive motility of sperms, and their viability definitely increased.

Conclusion: Selegiline can successfully be used to stop/counterbalance certain symptoms of aging.

背景:斯来吉兰用于治疗帕金森病患者。最近还发现了使用它的其他迹象。目的:发现司来吉兰治疗的特殊有益副作用。方法:2岁雄性Wistar大鼠每日皮下注射0.25 mg/kg斯来吉兰s.c。这些大鼠在治疗四周后被处死。结果:睾丸质量、精子数量、精子进行性运动能力和活力明显提高。结论:司来吉兰可以成功地阻止/平衡某些衰老症状。
{"title":"Effects on Sperms' Quality of Selegiline in Aged Rats.","authors":"Huba Kalász,&nbsp;Julianna Thuróczy,&nbsp;Gellért Karvaly,&nbsp;Lajos Balogh,&nbsp;István Gyertyán,&nbsp;Edit Tóth-Molnár,&nbsp;Ernest Adeghate,&nbsp;Kornélia Tekes","doi":"10.2174/1874104501711010138","DOIUrl":"https://doi.org/10.2174/1874104501711010138","url":null,"abstract":"<p><strong>Background: </strong>Selegiline is used to treat Parkinsonian patients. Other indications of its use have recently been discovered.</p><p><strong>Objective: </strong>Scouting special and beneficial side effects of selegiline treatment.</p><p><strong>Method: </strong>Two-year old male Wistar rats were daily treated with 0.25 mg/kg of selegiline s.c. (subcutaneous injection). The rats were sacrificed following a four-weeks' treatment.</p><p><strong>Results: </strong>Mass of testes, number of sperms, progressive motility of sperms, and their viability definitely increased.</p><p><strong>Conclusion: </strong>Selegiline can successfully be used to stop/counterbalance certain symptoms of aging.</p>","PeriodicalId":39133,"journal":{"name":"Open Medicinal Chemistry Journal","volume":"11 ","pages":"138-145"},"PeriodicalIF":0.0,"publicationDate":"2017-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748828/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35782965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Molecular Docking, Pharmacophore, and 3D-QSAR Approach: Can Adenine Derivatives Exhibit Significant Inhibitor Towards Ebola Virus? 分子对接,药效团和3D-QSAR方法:腺嘌呤衍生物能对埃博拉病毒表现出显著的抑制剂吗?
Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2017-11-30 eCollection Date: 2017-01-01 DOI: 10.2174/1874104501711010127
Amit Rai, Mohamed H Aboumanei, Suraj P Verma, Sachidanand Kumar, Vinit Raj

Introduction: Ebola Virus Disease (EVD) is caused by Ebola virus, which is often accompanied by fatal hemorrhagic fever upon infection in humans. This virus has caused the majority of deaths in human. There are no proper vaccinations and medications available for EVD. It is pivoting the attraction of scientist to develop the potent vaccination or novel lead to inhibit Ebola virus.

Methods & materials: In the present study, we developed 3D-QSAR and the pharmacophoric model from the previous reported potent compounds for the Ebola virus.

Results & discussion: Results & Discussion: The pharmacophoric model AAAP.116 was generated with better survival value and selectivity. Moreover, the 3D-QSAR model also showed the best r2 value 0.99 using PLS factor. Thereby, we found the higher F value, which demonstrated the statistical significance of both the models. Furthermore, homological modeling and molecular docking study were performed to analyze the affinity of the potent lead. This showed the best binding energy and bond formation with targeted protein.

Conclusion: Finally, all the results of this study concluded that 3D-QSAR and Pharmacophore models may be helpful to search potent lead for EVD treatment in future.

埃博拉病毒病(EVD)是由埃博拉病毒引起的疾病,人感染后常伴有致命的出血热。这种病毒导致了大多数人类死亡。目前还没有针对埃博拉病毒病的适当疫苗和药物。研发抑制埃博拉病毒的强效疫苗或新型先导剂正吸引着科学家的注意力。方法与材料:在本研究中,我们从先前报道的埃博拉病毒有效化合物中建立了3D-QSAR和药效模型。结果与讨论:产生的药效模型AAAP.116具有较好的生存价值和选择性。此外,使用PLS因子的3D-QSAR模型也显示出最佳的r2值0.99。因此,我们发现F值较高,这表明两个模型的统计显著性。此外,我们还进行了同源性建模和分子对接研究,分析了强效铅的亲和力。结果表明,该蛋白与目标蛋白的结合能和成键能力最佳。结论:本研究的所有结果表明,3D-QSAR和药效团模型可能有助于未来寻找EVD治疗的有效线索。
{"title":"Molecular Docking, Pharmacophore, and 3D-QSAR Approach: Can Adenine Derivatives Exhibit Significant Inhibitor Towards Ebola Virus?","authors":"Amit Rai,&nbsp;Mohamed H Aboumanei,&nbsp;Suraj P Verma,&nbsp;Sachidanand Kumar,&nbsp;Vinit Raj","doi":"10.2174/1874104501711010127","DOIUrl":"https://doi.org/10.2174/1874104501711010127","url":null,"abstract":"<p><strong>Introduction: </strong>Ebola Virus Disease (EVD) is caused by Ebola virus, which is often accompanied by fatal hemorrhagic fever upon infection in humans. This virus has caused the majority of deaths in human. There are no proper vaccinations and medications available for EVD. It is pivoting the attraction of scientist to develop the potent vaccination or novel lead to inhibit Ebola virus.</p><p><strong>Methods & materials: </strong>In the present study, we developed 3D-QSAR and the pharmacophoric model from the previous reported potent compounds for the Ebola virus.</p><p><strong>Results & discussion: </strong>Results & Discussion: The pharmacophoric model AAAP.116 was generated with better survival value and selectivity. Moreover, the 3D-QSAR model also showed the best r2 value 0.99 using PLS factor. Thereby, we found the higher F value, which demonstrated the statistical significance of both the models. Furthermore, homological modeling and molecular docking study were performed to analyze the affinity of the potent lead. This showed the best binding energy and bond formation with targeted protein.</p><p><strong>Conclusion: </strong>Finally, all the results of this study concluded that 3D-QSAR and Pharmacophore models may be helpful to search potent lead for EVD treatment in future.</p>","PeriodicalId":39133,"journal":{"name":"Open Medicinal Chemistry Journal","volume":"11 ","pages":"127-137"},"PeriodicalIF":0.0,"publicationDate":"2017-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748831/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35782963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Prodrugs of NSAIDs: A Review. 非甾体抗炎药的原药:综述。
Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2017-11-30 eCollection Date: 2017-01-01 DOI: 10.2174/1874104501711010146
Kamal Shah, Jeetendra K Gupta, Nagendra S Chauhan, Neeraj Upmanyu, Sushant K Shrivastava, Pradeep Mishra

Intoroduction: Prodrug approach deals with chemical biotransformation or enzymatic conversion or involves inactive or less active bio-reversible derivatives of active drug molecules. They have to pass through enzymatic or chemical biotransformation before eliciting their pharmacological action.

Methods & materials: The two different pharmacophores combine to give synergistic activity or may help in targeting the active drug to its target. Prodrug super seeds the problems of prodrug designing, for example solubility enhancement, bioavailability enhancement, chemical stability improvement, presystemic metabolism, site specific delivery, toxicity masking, improving patient acceptance, or eradicating undesirable adverse effects.

Results: As an outcome the search for a prodrug or mutual prodrug with reduced toxicity has continued during recent years. This present review emphasizes the common help to revamp physiochemical, pharmaceutical and therapeutic effectiveness of drugs.

Conclusion: This gives the researcher a common platform where they can find prodrugs of commonly used NSAIDs to overcome the gastrointestinal toxicity (irritation, ulcergenocity and bleeding).

内吸法:原药方法涉及化学生物转化或酶转化,或涉及活性药物分子的非活性或活性较低的生物可逆衍生物。它们必须经过酶或化学生物转化才能发挥药理作用:两种不同的药理作用结合在一起,可产生协同活性,或有助于将活性药物靶向作用于靶点。原药超级种子解决了原药设计的各种问题,例如提高溶解度、生物利用度、化学稳定性、系统前代谢、特定部位给药、毒性掩蔽、提高病人接受度或消除不良反应:结果:近年来,人们一直在寻找毒性降低的原药或互利原药。结果:近年来,人们一直在寻找具有减毒作用的原药或互效原药。本综述强调了这一共同的帮助,以改善药物的理化、制药和治疗效果:结论:这为研究人员提供了一个共同的平台,使他们可以找到常用非甾体抗炎药的原药,以克服胃肠道毒性(刺激、溃疡和出血)。
{"title":"Prodrugs of NSAIDs: A Review.","authors":"Kamal Shah, Jeetendra K Gupta, Nagendra S Chauhan, Neeraj Upmanyu, Sushant K Shrivastava, Pradeep Mishra","doi":"10.2174/1874104501711010146","DOIUrl":"10.2174/1874104501711010146","url":null,"abstract":"<p><strong>Intoroduction: </strong>Prodrug approach deals with chemical biotransformation or enzymatic conversion or involves inactive or less active bio-reversible derivatives of active drug molecules. They have to pass through enzymatic or chemical biotransformation before eliciting their pharmacological action.</p><p><strong>Methods & materials: </strong>The two different pharmacophores combine to give synergistic activity or may help in targeting the active drug to its target. Prodrug super seeds the problems of prodrug designing, for example solubility enhancement, bioavailability enhancement, chemical stability improvement, presystemic metabolism, site specific delivery, toxicity masking, improving patient acceptance, or eradicating undesirable adverse effects.</p><p><strong>Results: </strong>As an outcome the search for a prodrug or mutual prodrug with reduced toxicity has continued during recent years. This present review emphasizes the common help to revamp physiochemical, pharmaceutical and therapeutic effectiveness of drugs.</p><p><strong>Conclusion: </strong>This gives the researcher a common platform where they can find prodrugs of commonly used NSAIDs to overcome the gastrointestinal toxicity (irritation, ulcergenocity and bleeding).</p>","PeriodicalId":39133,"journal":{"name":"Open Medicinal Chemistry Journal","volume":"11 ","pages":"146-195"},"PeriodicalIF":0.0,"publicationDate":"2017-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748882/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35782966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synthesis and Biological Evaluation of Novel Hybrid Molecules Containing Purine, Coumarin and Isoxazoline or Isoxazole Moieties. 含有嘌呤、香豆素和异恶唑啉或异恶唑基团的新型杂化分子的合成及生物学评价。
Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2017-11-30 eCollection Date: 2017-01-01 DOI: 10.2174/1874104501711010196
Michael G Kallitsakis, Angelo Carotti, Marco Catto, Aikaterini Peperidou, Dimitra J Hadjipavlou-Litina, Konstantinos E Litinas

Introduction: The 1,3-dipolar cycloaddition reactions of nitrile oxides formed in situ (in the presence of NCS and Et3N) from the oximes of (purin-9-yl)acetaldehyde or (coumarinyloxy)acetaldehyde with allyloxycoumarins or 9-allylpurines, respectively resulted in 3,5-disubstituted isoxazolines. The similar reactions of propargyloxycoumarins or 9-propargylpurines led to 3,5-disubstituted isoxazoles by treatment with PIDA and catalytic amount of TFA.

Methods: The new compounds were tested in vitro as antioxidant agents and inhibitors of soybean lipoxygenase LO, AChE and MAO-B.

Results: The majority of the compounds showed significant hydroxyl radical scavenging activity. Compounds 4k and 4n presented LO inhibitory activity.

Conclusion: Compound 13e presents an antioxidant significant profile combining anti-LO, anti-AChE and anti-MAO-B activities.

在NCS和Et3N的存在下,由(purin-9-yl)乙醛或(coumarinyloxy)乙醛的肟类与烯丙基香豆素或9-烯丙基嘌呤在原位形成的腈氧化物的1,3-偶极环加成反应,分别生成3,5-二取代异恶唑啉。用PIDA和TFA催化量处理丙基氧香豆素和9-丙基嘌呤,得到3,5-二取代异恶唑。结果:大部分化合物具有明显的羟基自由基清除活性。化合物4k和4n具有LO抑制活性。结论:化合物13e具有显著的抗lo、抗ache和抗mao - b活性。
{"title":"Synthesis and Biological Evaluation of Novel Hybrid Molecules Containing Purine, Coumarin and Isoxazoline or Isoxazole Moieties.","authors":"Michael G Kallitsakis,&nbsp;Angelo Carotti,&nbsp;Marco Catto,&nbsp;Aikaterini Peperidou,&nbsp;Dimitra J Hadjipavlou-Litina,&nbsp;Konstantinos E Litinas","doi":"10.2174/1874104501711010196","DOIUrl":"https://doi.org/10.2174/1874104501711010196","url":null,"abstract":"<p><strong>Introduction: </strong>The 1,3-dipolar cycloaddition reactions of nitrile oxides formed <i>in situ</i> (in the presence of NCS and Et<sub>3</sub>N) from the oximes of (purin-9-yl)acetaldehyde or (coumarinyloxy)acetaldehyde with allyloxycoumarins or 9-allylpurines, respectively resulted in 3,5-disubstituted isoxazolines. The similar reactions of propargyloxycoumarins or 9-propargylpurines led to 3,5-disubstituted isoxazoles by treatment with PIDA and catalytic amount of TFA.</p><p><strong>Methods: </strong>The new compounds were tested <i>in vitro</i> as antioxidant agents and inhibitors of soybean lipoxygenase LO, AChE and MAO-B.</p><p><strong>Results: </strong>The majority of the compounds showed significant hydroxyl radical scavenging activity. Compounds <b>4k</b> and <b>4n</b> presented LO inhibitory activity.</p><p><strong>Conclusion: </strong>Compound <b>13</b>e presents an antioxidant significant profile combining anti-LO, anti-AChE and anti-MAO-B activities.</p>","PeriodicalId":39133,"journal":{"name":"Open Medicinal Chemistry Journal","volume":"11 ","pages":"196-211"},"PeriodicalIF":0.0,"publicationDate":"2017-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/1874104501711010196","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35781836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
A Review on the Modification of Polysaccharide Through Graft Copolymerization for Various Potential Applications. 综述通过接枝共聚改性多糖的各种潜在应用。
Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2017-09-26 eCollection Date: 2017-01-01 DOI: 10.2174/1874104501711010109
Deepak Kumar, Jyoti Pandey, Vinit Raj, Pramendra Kumar

Introduction: Graft copolymerization is one of the most promising technique uses to modify the properties of naturally available polymers with a minimum loss in their native characteristics.

Methods and materials: Graft copolymerization is a very significant technique to add hybrid properties in backbone of polymers. The grafting generally initiated through the formation of free radical centers on the polymer backbone as well as monomer.

Results: Grafted polysaccharides have various applications in different important scientific areas such as drug delivery, pharmaceutical field, plastic industry, waste water treatment, tannery effluent treatment, textile industry, agriculture area, etc. all of this fascinated us to summarize the major research articles over the last two decades outlining different methods of grafting, surface modification, graft copolymerization of synthetic and natural polymers.

Conclusion: Various redox initiator systems viz. Ceric ammonium nitrate, per sulfate, Irradiation, FAS-H2O2etc. is also explored for grafting of vinyl through conventional and non-conventional techniques.

简介接枝共聚是一种最有前途的技术,可用于改变天然聚合物的特性,同时将其原生特性的损失降到最低:接枝共聚是在聚合物骨架中添加混合特性的一项非常重要的技术。接枝通常是通过在聚合物骨架和单体上形成自由基中心而开始的:接枝多糖在药物输送、制药领域、塑料工业、废水处理、制革废水处理、纺织工业、农业领域等不同重要科学领域都有各种应用。所有这些都促使我们总结过去二十年来的主要研究文章,概述合成聚合物和天然聚合物的接枝、表面改性、接枝共聚等不同方法:结论:各种氧化还原引发剂体系,如硝酸铈铵、硫酸盐、辐照、FAS-H2O2 等,也被用于通过常规和非常规技术接枝乙烯基。
{"title":"A Review on the Modification of Polysaccharide Through Graft Copolymerization for Various Potential Applications.","authors":"Deepak Kumar, Jyoti Pandey, Vinit Raj, Pramendra Kumar","doi":"10.2174/1874104501711010109","DOIUrl":"10.2174/1874104501711010109","url":null,"abstract":"<p><strong>Introduction: </strong>Graft copolymerization is one of the most promising technique uses to modify the properties of naturally available polymers with a minimum loss in their native characteristics.</p><p><strong>Methods and materials: </strong>Graft copolymerization is a very significant technique to add hybrid properties in backbone of polymers. The grafting generally initiated through the formation of free radical centers on the polymer backbone as well as monomer.</p><p><strong>Results: </strong>Grafted polysaccharides have various applications in different important scientific areas such as drug delivery, pharmaceutical field, plastic industry, waste water treatment, tannery effluent treatment, textile industry, agriculture area, <i>etc</i>. all of this fascinated us to summarize the major research articles over the last two decades outlining different methods of grafting, surface modification, graft copolymerization of synthetic and natural polymers.</p><p><strong>Conclusion: </strong>Various redox initiator systems <i>viz.</i> Ceric ammonium nitrate, per sulfate, Irradiation, FAS-H<sub>2</sub>O<sub>2</sub><i>etc</i>. is also explored for grafting of vinyl through conventional and non-conventional techniques.</p>","PeriodicalId":39133,"journal":{"name":"Open Medicinal Chemistry Journal","volume":"11 ","pages":"109-126"},"PeriodicalIF":0.0,"publicationDate":"2017-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676014/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35261400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pyrrolyl Pyrazoline Carbaldehydes as Enoyl-ACP Reductase Inhibitors: Design, Synthesis and Antitubercular Activity. 吡咯基吡唑啉醛作为烯酰acp还原酶抑制剂:设计、合成和抗结核活性。
Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2017-09-26 eCollection Date: 2017-01-01 DOI: 10.2174/1874104501711010092
Sheshagiri R Dixit, Shrinivas D Joshi, Venkatarao H Kulkarni, Sunil S Jalalpure, Vijay M Kumbar, Tulasigiriyappa Y Mudaraddi, Mallikarjuna N Nadagouda, Tejraj M Aminabhavi

Introduction: In efforts to develop new antitubercular (anti-TB) compounds, herein we describe cytotoxic evaluation of 15 newly synthesized pyrrolyl pyrazoline carbaldehydes.

Method & materials: Surflex-Docking method was used to study binding modes of the compounds at the active site of the enzyme enoyl ACP reductase from Mycobacterium tuberculosis (M. tuberculosis), which plays an important role in FAS-II biosynthetic pathway of M. tuberculosis and also it is an important target for designing novel anti-TB agents.

Results: Among the synthesized compounds, compounds 4g and 4i showed H-bonding interactions with MET98, TYR158 and co-factor NAD+, all of which fitted well within the binding pocket of InhA. Also, these compounds have shown the same type of interaction as that of 4TZK ligand. The compounds were further evaluated for preliminary anti-TB activities against M. tuberculosis H37Rv strain.

Conclusion: Some compounds were also screened for their mammalian cell toxicity using human lung cancer cell-line (A549) that was found to be nontoxic.

简介:为了开发新的抗结核化合物,本文描述了15种新合成的吡咯酰吡唑啉甲酸酯的细胞毒性评价。方法与材料:采用曲面对接法研究结核分枝杆菌(Mycobacterium tuberculosis, M. tuberculosis)酶烯丙基ACP还原酶活性位点化合物的结合模式,该酶在结核分枝杆菌FAS-II生物合成途径中起重要作用,也是设计新型抗结核药物的重要靶点。结果:在合成的化合物中,化合物4g和4i与MET98、TYR158和辅因子NAD+均表现出h键相互作用,均与InhA的结合口袋内吻合良好。此外,这些化合物显示出与4TZK配体相同的相互作用类型。进一步评价了化合物对结核分枝杆菌H37Rv株的初步抗结核活性。结论:利用人肺癌细胞系(A549)对某些化合物进行了哺乳动物细胞毒性筛选,发现它们是无毒的。
{"title":"Pyrrolyl Pyrazoline Carbaldehydes as Enoyl-ACP Reductase Inhibitors: Design, Synthesis and Antitubercular Activity.","authors":"Sheshagiri R Dixit,&nbsp;Shrinivas D Joshi,&nbsp;Venkatarao H Kulkarni,&nbsp;Sunil S Jalalpure,&nbsp;Vijay M Kumbar,&nbsp;Tulasigiriyappa Y Mudaraddi,&nbsp;Mallikarjuna N Nadagouda,&nbsp;Tejraj M Aminabhavi","doi":"10.2174/1874104501711010092","DOIUrl":"https://doi.org/10.2174/1874104501711010092","url":null,"abstract":"<p><strong>Introduction: </strong>In efforts to develop new antitubercular (anti-TB) compounds, herein we describe cytotoxic evaluation of 15 newly synthesized pyrrolyl pyrazoline carbaldehydes.</p><p><strong>Method & materials: </strong>Surflex-Docking method was used to study binding modes of the compounds at the active site of the enzyme enoyl ACP reductase from <i>Mycobacterium tuberculosis (M. tuberculosis)</i>, which plays an important role in FAS-II biosynthetic pathway of <i>M. tuberculosis</i> and also it is an important target for designing novel anti-TB agents.</p><p><strong>Results: </strong>Among the synthesized compounds, compounds <b>4g</b> and <b>4i</b> showed H-bonding interactions with MET98, TYR158 and co-factor NAD<sup>+</sup>, all of which fitted well within the binding pocket of InhA. Also, these compounds have shown the same type of interaction as that of 4TZK ligand. The compounds were further evaluated for preliminary anti-TB activities against <i>M. tuberculosis</i> H37Rv strain.</p><p><strong>Conclusion: </strong>Some compounds were also screened for their mammalian cell toxicity using human lung cancer cell-line (A549) that was found to be nontoxic.</p>","PeriodicalId":39133,"journal":{"name":"Open Medicinal Chemistry Journal","volume":"11 ","pages":"92-108"},"PeriodicalIF":0.0,"publicationDate":"2017-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676022/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35261399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Synthesis and Anticancer Evaluation of Some New 3-Benzyl-4,8-Dimethylbenzopyrone Derivatives. 一些新的3-苄基-4,8-二甲基苯并吡酮衍生物的合成及抗癌评价。
Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2017-09-21 eCollection Date: 2017-01-01 DOI: 10.2174/1874104501711010081
Sohair L El-Ansary, Doaa E Abdel Rahman, Lina M A Abdel Ghany

Introduction: New benzopyrone derivatives such as Schiff's like compounds, acetohydrazides or substituted with oxadiazole or pyrazole heterocycles were synthesized from parent acid hydrazide compound 3.

Methods and materials: Structures of the synthesized compounds were elucidated using IR, NMR and mass spectroscopy. All the synthesized derivatives were selected by National Cancer Institute (NCI), Bethesda, and evaluated for their in vitro anticancer activity in the full NCI 60 cell lines panel assay.

Results and conclusion: Schiffs like compounds 4a, b and c were found to have good growth inhibition % against numerous cell lines that belong mainly to leukemia, non-small cell lung, CNS and breast Cancer subpanels.

以母体酸性肼化合物3为原料合成了新的苯并吡酮类化合物,如席夫类化合物、乙酰肼类化合物或被恶二唑或吡唑取代的杂环类化合物。方法与材料:利用红外光谱、核磁共振光谱和质谱对合成的化合物进行了结构鉴定。所有合成的衍生物均由美国国家癌症研究所(NCI) Bethesda进行筛选,并在NCI 60细胞系小组实验中评估其体外抗癌活性。结果和结论:发现希夫斯样化合物4a, b和c对主要属于白血病,非小细胞肺,中枢神经系统和乳腺癌亚组的许多细胞系具有良好的生长抑制%。
{"title":"Synthesis and Anticancer Evaluation of Some New 3-Benzyl-4,8-Dimethylbenzopyrone Derivatives.","authors":"Sohair L El-Ansary,&nbsp;Doaa E Abdel Rahman,&nbsp;Lina M A Abdel Ghany","doi":"10.2174/1874104501711010081","DOIUrl":"https://doi.org/10.2174/1874104501711010081","url":null,"abstract":"<p><strong>Introduction: </strong>New benzopyrone derivatives such as Schiff's like compounds, acetohydrazides or substituted with oxadiazole or pyrazole heterocycles were synthesized from parent acid hydrazide compound <b>3</b>.</p><p><strong>Methods and materials: </strong>Structures of the synthesized compounds were elucidated using IR, NMR and mass spectroscopy. All the synthesized derivatives were selected by National Cancer Institute (NCI), Bethesda, and evaluated for their <i>in vitro</i> anticancer activity in the full NCI 60 cell lines panel assay.</p><p><strong>Results and conclusion: </strong>Schiffs like compounds <b>4a, b</b> and <b>c</b> were found to have good growth inhibition % against numerous cell lines that belong mainly to leukemia, non-small cell lung, CNS and breast Cancer subpanels.</p>","PeriodicalId":39133,"journal":{"name":"Open Medicinal Chemistry Journal","volume":"11 ","pages":"81-91"},"PeriodicalIF":0.0,"publicationDate":"2017-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676012/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35261398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
期刊
Open Medicinal Chemistry Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1